Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC underexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MYC overexpression (18)

MYC expression (9)

BCL2 expression + MYC expression (8)

MYC overexpression + BCL2 overexpression (7)

MYC positive (3)

MYC expression + BCL2 expression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

MYC overexpression (18)

MYC expression (9)

BCL2 expression + MYC expression (8)

MYC overexpression + BCL2 overexpression (7)

MYC positive (3)

MYC expression + BCL2 expression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

›

MYC underexpression	T Acute Lymphoblastic Leukemia	MYC underexpression	T Acute Lymphoblastic Leukemia	venetoclax + NBL-001 Sensitive: D – Preclinical venetoclax + NBL-001 Sensitive : D	venetoclax + NBL-001 Sensitive: D – Preclinical venetoclax + NBL-001 Sensitive : D
MYC underexpression	Breast Cancer	MYC underexpression	Breast Cancer	ribociclib Sensitive: D – Preclinical ribociclib Sensitive : D	ribociclib Sensitive: D – Preclinical ribociclib Sensitive : D